This content is from: Home

Green light for generic rival to Nexium

Indian company Ranbaxy has been given clearance to launch a generic rival to AstraZeneca’s gastrointestinal drug Nexium in the UK

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial